Maverick Capital Ltd. Makes New Investment in Globe Life Inc. $GL

Maverick Capital Ltd. purchased a new stake in Globe Life Inc. (NYSE:GL) in the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 11,081 shares of the company’s stock, valued at approximately $1,542,000.

A number of other institutional investors have also modified their holdings of GL. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life during the second quarter worth about $28,000. Hilton Head Capital Partners LLC bought a new stake in Globe Life in the 4th quarter valued at about $30,000. MUFG Securities EMEA plc acquired a new position in Globe Life during the 2nd quarter valued at about $31,000. Torren Management LLC acquired a new position in Globe Life during the 4th quarter valued at about $37,000. Finally, AdvisorNet Financial Inc grew its position in Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after purchasing an additional 92 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Globe Life Stock Performance

Shares of NYSE GL opened at $174.34 on Tuesday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $13.54 billion, a price-to-earnings ratio of 11.58 and a beta of 0.47. The stock’s fifty day simple moving average is $169.41 and its 200 day simple moving average is $153.24. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the previous year, the business earned $3.05 earnings per share. The business’s quarterly revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, sell-side analysts forecast that Globe Life Inc. will post 15.7 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is presently 8.76%.

Insider Buying and Selling

In other news, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the transaction, the director owned 16,621 shares in the company, valued at approximately $2,979,148.04. This trade represents a 33.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Frank M. Svoboda sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $156.68, for a total value of $3,133,600.00. Following the completion of the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at $8,463,853.60. The trade was a 27.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 85,524 shares of company stock worth $13,582,332. Insiders own 2.11% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. JPMorgan Chase & Co. boosted their price target on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. TD Cowen increased their price target on Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Keefe, Bruyette & Woods lowered their price target on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Morgan Stanley lifted their price objective on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Globe Life currently has a consensus rating of “Moderate Buy” and a consensus price target of $187.40.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.